Catalyst
Slingshot members are tracking this event:
Dynavax Technologies (DVAX) FDA PDUFA decision due on August 10th for Hepatitis-B vaccine HEPLISAV-B, after receiving complete response letter (CRL) from previous application
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| DVAX |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 03, 2017
Occurred Source:
http://investors.dynavax.com/releasedetail.cfm?ReleaseID=1035975
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Hepatitis-b, Heplisav-b, Complete Response Letter, Pdufa Date
